Dysfunction of mitochondrial complex I and the proteasome: Interactions between two biochemical deficits in a cellular model of Parkinson's disease

238Citations
Citations of this article
107Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Two biochemical deficits have been described in the substantia nigra in Parkinson's disease, decreased activity of mitochondrial complex I and reduced proteasomal activity. We analysed interactions between these deficits in primary mesencephalic cultures. Proteasome inhibitors (epoxomicin, MG132) exacerbated the toxicity of complex I inhibitors [rotenone, 1-methyl-4-phenylpyridinium (MPP+)] and of the toxic dopamine analogue 6-hydroxydopamine, but not of inhibitors of mitochondrial complex II-V or excitotoxins [N-methyl-D-aspartate (NMDA), kainate]. Rotenone and MPP + increased free radicals and reduced proteasomal activity via adenosine triphosphate (ATP) depletion. 6-hydroxydopamine also increased free radicals, but did not affect ATP levels and increased proteasomal activity, presumably in response to oxidative damage. Proteasome inhibition potentiated the toxicity of rotenone, MPP+ and 6-hydroxydopamine at concentrations at which they increased free radical levels ≥ 40% above baseline, exceeding the cellular capacity to detoxify oxidized proteins reduced by proteasome inhibition, and also exacerbated ATP depletion caused by complex I inhibition. Consistently, both free radical scavenging and stimulation of ATP production by glucose supplementation protected against the synergistic toxicity. In summary, proteasome inhibition increases neuronal vulnerability to normally subtoxic levels of free radicals and amplifies energy depletion following complex I inhibition.

References Powered by Scopus

Mutation in the α-synuclein gene identified in families with Parkinson's disease

7165Citations
N/AReaders
Get full text

α-synuclein in Lewy bodies [8]

6879Citations
N/AReaders
Get full text

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

4477Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Mitochondria take center stage in aging and neurodegeneration

824Citations
N/AReaders
Get full text

Expanding insights of mitochondrial dysfunction in Parkinson's disease

751Citations
N/AReaders
Get full text

The scientific and clinical basis for the treatment of Parkinson disease (2009)

731Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Höglinger, G. U., Carrard, G., Michel, P. P., Medja, F., Lombès, A., Ruberg, M., … Hirsch, E. C. (2003). Dysfunction of mitochondrial complex I and the proteasome: Interactions between two biochemical deficits in a cellular model of Parkinson’s disease. Journal of Neurochemistry, 86(5), 1297–1307. https://doi.org/10.1046/j.1471-4159.2003.01952.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 49

64%

Researcher 16

21%

Professor / Associate Prof. 10

13%

Lecturer / Post doc 2

3%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 36

50%

Biochemistry, Genetics and Molecular Bi... 14

19%

Medicine and Dentistry 12

17%

Neuroscience 10

14%

Save time finding and organizing research with Mendeley

Sign up for free